Minerva Neurosciences
NERV
28 hedge funds and large institutions have $75.6M invested in Minerva Neurosciences in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
37% more capital invested
Capital invested by funds: $55.1M → $75.6M (+$20.5M)
33% more funds holding
Funds holding: 21 → 28 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.24M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.26M |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$287K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$242K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.31M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$97K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$854 |
| 5 |
Citigroup
New York
|
-$43 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $4K | -$854 | -20 | -19% |
|
27
Wells Fargo
San Francisco,
California
| $2K | +$2.13K | +50 | New |
|
28
Geode Capital Management
Boston,
Massachusetts
| $216 | +$20.5K | +481 | +12% |
|
|
29
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$97K | -1,990 | Closed |
|
|
30
Creative Planning
Overland Park,
Kansas
| – | -$2K | -38 | Closed |
|
NERV Hedge Fund Activity: Q1 2016 in Review
28 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2016, worth a combined $75.6M — up 37% from $55.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NERV positions and 2 closed out — a net gain of 7 holders — while 10 added to existing stakes and 3 trimmed.
The largest buyer was Federated Hermes, adding an estimated $13M. The largest seller was Highland Capital Management (Texas), cutting an estimated $2.31M.
- 28 institutional investors held Minerva Neurosciences (NERV) as of Q1 2016, up from 21 in Q4 2015.
- Funds reported $75.6M of Minerva Neurosciences stock for Q1 2016, up 37% quarter-over-quarter.
- 9 funds opened new Minerva Neurosciences positions in Q1 2016 and 2 closed out, a net change of +7 holders.
- The largest Minerva Neurosciences buyer in Q1 2016 was Federated Hermes, an estimated $13M added.
- The largest Minerva Neurosciences seller in Q1 2016 was Highland Capital Management (Texas), an estimated $2.31M sold.
Based on aggregated 13F filings for Q1 2016.